最新記事一覧

Vol.22220 現場からの医療改革推進協議会第十七回シンポジウム 抄録から(3-2)

医療ガバナンス学会 (2022年10月28日 15:00)


■ 関連タグ

*このシンポジウムの聴講をご希望の場合は事前申し込みが必要です。
下記、URLからお申込みください。
( https://genbasympo17.stores.jp/ )

2022年10月28日 MRIC by 医療ガバナンス学会 発行  http://medg.jp

11月26日(土)
【Session 03】世界各国のポストコロナ 15:05~15:55(司会:尾崎 章彦)

●A culturally tailored and faith-based health education approaches to prevention echinococcosis on the Qinghai-Tibet Plateau region in China
Jiwei Wang
(Associate Professor, School of Public Health, Fudan University, 中国)

Echinococcosis has been identified as a serious challenge to public health on the Qinghai-Tibet plateau region in China nowadays. This project will help to improve knowledge, attitude and behavior related to echinococcosis and compliance with local rules needed for managing their dogs and sheep, finally, reduce the incidence of echinococcosis among Tibetan herdsmen on Qinghai-Tibet Plateau region in China.

We develop the faith-based and cultured-tailed health education program for echinococcosis prevention refer to the Chronic Disease Self-Management Program and the Medical Research Council’ s five stage model. Tibetan Buddhist monasteries (TBMs) were recruited in 10 townships of 4 TBM, by the local community health service centers.

In phase I, the Leader’ s Manual would be developed that incorporated the problem solving, goal-setting and self-monitoring of behavior as well as changes in echinococcosis-related knowledge and attitude. In phase II, and a total of 40 leader in 20 Tibetan Buddhist monasteries (TBMs) with two leaders in one TBM, of intervention group would be trained for six lessons within one week. All leaders are religious workers in the TBM. In phases III, these two leaders of one TBM would implement 6 lessons of 1 lesson per month for about 20 Tibet herders based on the Leader’ s Manual. In phase IV, we evaluated the feasibility for others to use our active implementation model.

●Addressing industry influence in medical education: a brief international overview
Barbara Mintzes
(Associate Professor, The University of Sydney Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, オーストラリア. MD)

Surveys of medical students in a range of countries have shown that interactions with industry are common, especially during clinical training. Students also tend to be less critical of drug promotion if they have studied in environments with more permissive policies concerning industry interactions, and there is some research evidence of a negative effect on prescribing quality post-graduation.

National medical student associations have had a leading role in initiatives to address conflicts of interest in medical education, and to press for curriculum change to better prepare students for the ethical choices they will face concerning interactions with industry.

This presentation describes the research to date on medical faculties’ conflict of interest policies, and the important shifts in policy that have occurred as a result of student advocacy.

●Status of COI studies in China and its management
Yaolong Chen
(Professor, Evidence-Based MedicineCentre of Lanzhou University, 中国)

In the development process of Clinical Practice Guidelines (CPGs), Conflict of Interest(COI) is a series of economic, personal, or professional interests that may affect the objectivity or fairness of expert decision-making, and it is also one of the important factors that affect the reliability of the guidelines. The study shows that there are associations between guidelines or the members of working groups in many fields with pharmaceutical enterprises, but most guidelines do not disclose these associations fully and transparently.

In 2016, China had relevant literature on the statement and management of domestic guidelines on COI. However, through the assessment of China’s guidelines from 2019 to 2021, we found that the reporting quality on COI of Chinese guidelines still needs improvement. Therefore, in 2022, we updated and published the Guiding principles for the development/ revision of clinical diagnosis and treatment guidelines in China, with which we sorted out China’s measures to deal with COI in the guidelines and proposed a detailed description and assumption on this topic.

 

MRIC Global

お知らせ

 配信をご希望の方はこちらにメールをお願いします。

 MRICでは配信するメールマガジンへの医療に関わる記事の投稿を歓迎しております。
 投稿をご検討の方は「お問い合わせ」よりご連絡をお願いします。

関連タグ

月別アーカイブ

▲ページトップへ